Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Teva
Cantor Fitzgerald
Daiichi Sankyo
Argus Health
UBS
Boehringer Ingelheim
Johnson and Johnson
Federal Trade Commission
Baxter

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,341,744

« Back to Dashboard

Which drugs does patent 7,341,744 protect, and when does it expire?

Patent 7,341,744 protects FULYZAQ and is included in one NDA.

This patent has eighteen patent family members in thirteen countries.
Summary for Patent: 7,341,744
Title:Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
Abstract: Pharmaceutical compositions containing a proanthocyanidin polymer composition which are useful for the treatment and prevention of secretory diarrhea are provided. The invention specifically relates to pharmaceutical formulations of a proanthocyanidin polymer composition which has been isolated from a Croton spp. or a Calophyllum spp. In particular, the invention relates to a formulation of a proanthocyanidin polymer composition which protects the composition from the effects of stomach acid after oral administration, particularly to those formulations which are enteric coated. The invention also relates to methods of producing a directly compressible proanthocyanidin polymer composition, as well as compositions containing the directly compressible proanthocyanidin polymer composition.
Inventor(s): Rozhon; Edward James (El Granada, CA), Khandwala; Atul S. (San Carlos, CA), Sabouni; Akram (Fairport, NY), Balwani; Gul P. (Fremont, CA), Chan; Jody Wai-Han (Mountain View, CA), Sesin; David F. (San Carlos, CA)
Assignee: Napo Pharmaceuticals, Inc. (South San Francisco, CA)
Application Number:09/712,033
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 7,341,744

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Napo Pharms Inc FULYZAQ crofelemer TABLET, DELAYED RELEASE;ORAL 202292-001 Dec 31, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial SYMPTOMATIC RELIEF OF NON-INFECTIOUS DIARRHEA ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 7,341,744

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,323,195 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions ➤ Try a Free Trial
8,574,634 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,341,744

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 430477 ➤ Try a Free Trial
Australia 2030302 ➤ Try a Free Trial
Australia 4988197 ➤ Try a Free Trial
Australia 775330 ➤ Try a Free Trial
Canada 2269078 ➤ Try a Free Trial
Germany 69739394 ➤ Try a Free Trial
Denmark 0935417 ➤ Try a Free Trial
European Patent Office 0935417 ➤ Try a Free Trial
European Patent Office 2060183 ➤ Try a Free Trial
European Patent Office 2255661 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Deloitte
UBS
Healthtrust
US Army
Julphar
Colorcon
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot